Sun Pharmaceuticals’ arm gets USFDA nod for generic Doxil

05 Feb 2013 Evaluate

Sun Pharmaceuticals Industries’ subsidiary has received US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for generic version of Doxil, Doxorubicin HCI Liposome Injection USP 2mg/ml, packaged in 20mg/10ml and 50mg/25ml single use vials.

The generic Doxorubicin HCI Liposome Injection USP 2mg/ml is therapeutically equivalent to Doxil Liposome Injection 2mg/ml of Janssen Research and Development, LLC. Doxorubicin HCI Liposome Injection is used to treat patients with ovarian cancer that has progressed of recurred after platinum-based chemotherapy.

Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Peers
Company Name CMP
Sun Pharma Inds. 1722.00
Dr. Reddys Lab 1248.00
Cipla 1503.80
Zydus Lifesciences 914.60
Lupin 2097.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×